Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1

Cancer Prevention Research

Volumn 3, Issue 5, 2010, Pages 670-679

  Shim, Jung Hyun ^a,b   Su, Zheng Yuan ^a,c   Chae, Jung Il ^b   Kim, Dong Joon ^a   Zhu, Feng ^a   Wei Ya, Ma ^a   Bode, Ann M ^a   Yang, Chung S ^d   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Chonbuk National University   (South Korea)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; EPIGALLOCATECHIN GALLATE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RAS GTPASE ACTIVATING PROTEIN SH3 DOMAIN BINDING PROTEIN 1; RAS PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; HUMAN; LUNG CANCER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WILD TYPE;

ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; CARRIER PROTEINS; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; IMMUNOPRECIPITATION; LUNG NEOPLASMS; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SRC HOMOLOGY DOMAINS;

EID: 77952073947     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0185     Document Type: Article

References (30)

1. Duchesne M, Schweighoffer F, Parker F, et al. Identification of the SH3 domain of GAP as an essential sequence for Ras-GAP-mediated signaling. Science 1993;259:525-528 (Pubitemid 23058712)
2. Pomerance M, Thang MN, Tocque B, Pierre M. The Ras-GTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation. Mol Cell Biol 1996;16:3179-3186 (Pubitemid 26161315)
3. Leblanc V, Delumeau I, Tocque B. Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells. Oncogene 1999;18:4884-4889 (Pubitemid 29423572)
4. Parker F, Maurier F, Delumeau I, et al. A Ras-GTPase-activating protein SH3-domain-binding protein. Mol Cell Biol 1996;16:2561-2569
5. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002;296:1634-1635
6. Gallouzi IE, Parker F, Chebli K, et al. A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stability. Mol Cell Biol 1998;18:3956-3965 (Pubitemid 28287919)
7. Gray DA, Inazawa J, Gupta K, Wong A, Ueda R, Takahashi T. Elevated expression of Unph, a proto-oncogene at 3p21.3, in human lung tumors. Oncogene 1995;10:2179-2183
8. Malumbres M, Pellicer A. RAS pathways to cell cycle control and cell transformation. Front Biosci 1998;3:d887-912.
9. Tourriere H, Gallouzi IE, Chebli K, et al. RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization. Mol Cell Biol 2001;21:7747-7760 (Pubitemid 32988784)
10. Guitard E, Parker F, Millon R, Abecassis J, Tocque B. G3BP is over-expressed in human tumors and promotes S phase entry. Cancer Lett 2001;162:213-221 (Pubitemid 32056291)
11. Kim MM, Wiederschain D, Kennedy D, Hansen E, Yuan ZM. Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP). Oncogene 2007;26:4209-4215 (Pubitemid 46975801)
12. Chung JY, Huang C, Meng X, Dong Z, Yang CS. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res 1999;59:4610-4617 (Pubitemid 29428966)
13. Dong Z, Ma W, Huang C, Yang CS. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 1997;57:4414-4419
14. Yao K, Ye P, Zhang L, Tan J, Tang X, Zhang Y. Epigallocatechin gallate protects against oxidative stress-induced mitochondria-dependent apoptosis in human lens epithelial cells. Mol Vis 2008;14:217-223 (Pubitemid 351223392)
15. Chen L, Zhang HY. Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules 2007;12:946-957
16. He Z, Tang F, Ermakova S, et al. Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation. Mol Carcinog 2008;47:172-183 (Pubitemid 351409338)
17. Shankar S, Suthakar G, Srivastava RK. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front Biosci 2007;12:5039-5051
18. Umeda D, Yano S, Yamada K, Tachibana H. Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J Biol Chem 2008;283:3050-3058
19. Ahn HY, Hadizadeh KR, Seul C, Yun YP, Vetter H, Sachinidis A. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol Biol Cell 1999;10:1093-1104
20. Dona M, Dell'Aica I, Calabrese F, et al. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol 2003;170:4335-4341 (Pubitemid 36428203)
21. Shammas MA, Neri P, Koley H, et al. Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications. Blood 2006;108:2804-2810
22. Shim JH, Choi HS, Pugliese A, et al. (-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase. J Biol Chem 2008;283:28370-28379
23. Shim JH, Cho KJ, Lee KA, et al. E7-expressing HaCaT keratinocyte cells are resistant to oxidative stress-induced cell death via the induction of catalase. Proteomics 2005;5:2112-2122
24. O'Neill EE, Brock CJ, von Kriegsheim AF, et al. Towards complete analysis of the platelet proteome. Proteomics 2002;2:288-305.
25. Yang JY, Michod D, Walicki J, et al. Partial cleavage of RasGAP by caspases is required for cell survival in mild stress conditions. Mol Cell Biol 2004;24:10425-10436 (Pubitemid 39507879)
26. Irvine K, Stirling R, Hume D, Kennedy D. Rasputin, more promiscuous than ever: a review of G3BP. Int J Dev Biol 2004;48:1065-1077 (Pubitemid 40179573)
27. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002;42:25-54.
28. Yang CS, Lambert JD, Ju J, Lu G, Sang S. Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol Appl Pharmacol 2007;224:265-273 (Pubitemid 47592860)
29. Hou Z, Lambert JD, Chin KV, Yang CS. Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mutat Res 2004;555:3-19. (Pubitemid 39345394)
30. Choi N, Baumann M, Flentjie M, et al. Predictive factors in radiotherapy for non-small cell lung cancer: present status. Lung Cancer 2001;31:43-56. (Pubitemid 32012602)